These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 29992539)

  • 1. Prognostic role of soluble ST2 in acute coronary syndrome with diabetes.
    Jha D; Goenka L; Ramamoorthy T; Sharma M; Dhandapani VE; George M
    Eur J Clin Invest; 2018 Sep; 48(9):e12994. PubMed ID: 29992539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma levels of Mac-2 binding protein predict poor cardiovascular outcomes in patients with acute coronary syndrome.
    Xie H; Zhang Z; Chen L; Zhang P; Cui Y; Liu H; Ma H; Jiang Y; Wang Y; Yang L; Wu H; Cui L
    Coron Artery Dis; 2017 Dec; 28(8):683-689. PubMed ID: 28731888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus.
    Li WP; Neradilek MB; Gu FS; Isquith DA; Sun ZJ; Wu X; Li HW; Zhao XQ
    Cardiovasc Diabetol; 2017 Apr; 16(1):45. PubMed ID: 28381225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
    Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
    Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-941 as a promising biomarker for acute coronary syndrome.
    Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
    BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain.
    Marino R; Magrini L; Orsini F; Russo V; Cardelli P; Salerno G; Hur M; Di Somma S;
    Ann Lab Med; 2017 Mar; 37(2):137-146. PubMed ID: 28029000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, Clinical Characteristics, and Impact of Acute Coronary Syndrome Following Transcatheter Aortic Valve Replacement.
    Vilalta V; Asmarats L; Ferreira-Neto AN; Maes F; de Freitas Campos Guimarães L; Couture T; Paradis JM; Mohammadi S; Dumont E; Kalavrouziotis D; Delarochellière R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Dec; 11(24):2523-2533. PubMed ID: 30573061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention.
    Zhang Q; Hu M; Ma S
    J Atheroscler Thromb; 2021 Dec; 28(12):1289-1297. PubMed ID: 33551392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the long-term prognostic value of cystatin C to other indicators of renal function, markers of inflammation and systolic dysfunction among patients with acute coronary syndrome.
    Kilic T; Oner G; Ural E; Yumuk Z; Sahin T; Bildirici U; Acar E; Celikyurt U; Kozdag G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):552-8. PubMed ID: 19523634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term prognostic impact of cystatin C on acute coronary syndrome octogenarians with diabetes mellitus.
    Fu Z; Xue H; Guo J; Chen L; Dong W; Gai L; Liu H; Sun Z; Chen Y
    Cardiovasc Diabetol; 2013 Nov; 12():157. PubMed ID: 24182196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Plasma ADAMTS-9 Levels and Severity of Coronary Artery Disease.
    Wei M; Pan H; Guo K
    Angiology; 2021 Apr; 72(4):371-380. PubMed ID: 33307720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention.
    Wang G; Wang C; Zhang Y; Wang P; Ran C; Zhao L; Han L
    Coron Artery Dis; 2016 Sep; 27(6):483-9. PubMed ID: 27171362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry).
    Råmunddal T; Hoebers LP; Henriques JP; Dworeck C; Angerås O; Odenstedt J; Ioanes D; Olivecrona G; Harnek J; Jensen U; Aasa M; Albertsson P; Wedel H; Omerovic E
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1535-44. PubMed ID: 27491603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma interleukin-37 playing an important role in acute coronary syndrome through suppression of ROCK activation.
    Yang T; Fang F; Chen Y; Ma J; Xiao Z; Zou S; Zheng N; Yan D; Liao S; Chen S; Fang H; Yu C; Liu J; Dong M
    Oncotarget; 2017 Feb; 8(6):9686-9695. PubMed ID: 28039466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women Undergoing Coronary Angiography for Myocardial Infarction or Who Present With Multivessel Disease Have a Poorer Prognosis Than Men.
    Gijsberts CM; Santema BT; Asselbergs FW; de Kleijn DP; Voskuil M; Agostoni P; Cramer MJ; Vaartjes I; Hoefer IE; Pasterkamp G; den Ruijter HM
    Angiology; 2016 Jul; 67(6):571-81. PubMed ID: 26351289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
    Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
    PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of myeloperoxidase concentration in patients with acute coronary syndrome].
    Liu SC; Yi TC; Weng HY; Zhang L; Li YX; Mohetaboer M; Zhang Y; Jiang J; Li JP; Huo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Apr; 46(4):284-291. PubMed ID: 29747324
    [No Abstract]   [Full Text] [Related]  

  • 19. Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes.
    Lettino M; Andell P; Zeymer U; Widimsky P; Danchin N; Bardaji A; Barrabes JA; Cequier A; Claeys MJ; De Luca L; Dörler J; Erlinge D; Erne P; Goldstein P; Koul SM; Lemesle G; Lüscher TF; Matter CM; Montalescot G; Radovanovic D; Sendón JL; Tousek P; Weidinger F; Weston CFM; Zaman A; Li J; Jukema JW;
    Eur Heart J Cardiovasc Pharmacother; 2017 Oct; 3(4):198-213. PubMed ID: 28329196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.
    Schellings DA; Adiyaman A; Dambrink JE; Gosselink AM; Kedhi E; Roolvink V; Ottervanger JP; Van't Hof AW
    Vasc Health Risk Manag; 2016; 12():471-476. PubMed ID: 27920547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.